Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD80 Protein (CD80)

This Recombinant CD80 protein is produced in HEK-293 Cells.
Catalog No. ABIN7849732
$1,254.00
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 11 to 13 Business Days

Quick Overview for CD80 Protein (CD80) (ABIN7849732)

Target

See all CD80 Proteins
CD80

Protein Type

Recombinant

Origin

  • 25
  • 23
  • 7
  • 6
  • 3
  • 3
Human

Source

  • 26
  • 8
  • 8
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
HEK-293 Cells

Application

SDS-PAGE (SDS)

Purity

>85 % by SDS-PAGE
  • Purpose

    Recombinant Human CD80 Protein

    Endotoxin Level

    <1.0EU per μg of the protein as determined by the LAL method
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Buffer

    Lyophilized from sterile PBS, pH 7.4.

    Storage

    4 °C,-20 °C,-80 °C

    Storage Comment

    Ship at 4°C. Upon receipt, aliquot and store at -20°C or -80°C for long term. Avoid repeated freeze and thaw cycles.
  • Target

    CD80

    Alternative Name

    CD80

    Background

    Synonyms: B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7

    Description: Recombinant human CD80 protein at the C-terminus.

    Background: The B-lymphocyte activation antigen B7-1 (referred to as B7), also known as CD80, is a member of cell surface immunoglobulin superfamily and is expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. As costimulatory ligands, B7-1 which exists predominantly as dimer and the related protein B7-2, interact with the costimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expressed on T cells, and thus constitute one of the dominant pathways that regulate T cell activation and tolerance, cytokine production, and the generation of CTL. The B7/CD28/CTLA4 pathway has the ability to both positively and negatively regulate immune responses. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.

    Pathways

    TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
You are here:
Chat with us!